Inventor
PERICLES CALIAS
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07KPeptides19%
C12NMicroorganisms or enzymes19%
C12YEnzymes19%
A61MDevices for introducing media into, or onto, the body6%
PatentTitleYear
12,409,210CNS delivery of therapeutic agents202512,168,041Methods and compositions for CNS delivery of arylsulfatase A202412,161,702Methods and compositions for CNS delivery of heparan N-sulfatase202412,121,569Methods and compositions for CNS delivery of iduronate-2-sulfatase202411,986,616Access port system for intrathecal drug delivery with self-adjusting catheter length202411,504,515Access port system with self-adjusting catheter length202211,471,516CNS delivery of therapeutic agents202211,260,112Methods and compositions for CNS delivery of iduronate-2-sulfatase2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to IMOTIK BIOSOLUTIONS LLC (2)· patent assignee history
2022Patents assigned to SHIRE HUMAN GENETIC THERAPIES (2)· patent assignee history
2022–2025Based in US· patent location history
2024–2025Patents assigned to TAKEDA PHARMACEUTICALS CO (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 4 | 2024–2025 |
| IMOTIK BIOSOLUTIONS LLC | 2 | 2022–2024 |
| SHIRE HUMAN GENETIC THERAPIES | 2 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2025 |